Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 3152 (MIR3152) is a short, non-coding RNA molecule classified as a microRNA in humans[1]. MicroRNAs are 20–24 nucleotides in length and regulate gene expression post-transcriptionally by binding to complementary sequences on target mRNAs, primarily resulting in translational inhibition or transcript destabilization[1][2][3][4]. Like other human microRNAs, MIR3152 is processed from a primary transcript by the Drosha and Dicer enzymes and is believed to function via the RNA-induced silencing complex (RISC)[1][2]. There are no well-characterized biological or disease roles specifically attributed to MIR3152, nor any reported interactions with drugs or biomarker usage. As a member of the microRNA family, its primary function is likely regulatory in gene expression, but specific targets or physiological impacts are not described in current databases[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 3152 (MIR3152).